Fri, January 7, 2022

Drew Ranieri Maintained (AVNS) at Sell with Decreased Target to $36 on, Jan 7th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-36-on-jan-7th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $37 to $36 on, Jan 7th, 2022.

Drew, nor any peers, have made any analyst calls on AVNS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30